中华医学杂志（英文版）2021，Vol.134Issue(11)：1299-1309,11.DOI:10.1097/CM9.0000000000001463
Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma:a multicenter,open-label,single-arm,phase 3 study
Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma:a multicenter,open-label,single-arm,phase 3 study
Yuan-Kai Shi 1Jian-Qiu Wu 2Ming-Zhi Zhang 3Jie Jin 4Xiao-Yan Ke 5Wei Li 6De-Pei Wu 7Shen-Miao Yang 8Xin Du 9Yong-Qian Jia 10Ai-Chun Liu 11Xiao-Nan Hong 12Dai-Hong Liu 13Zhi-Xiang Shen 14Lian-Sheng Zhang 15Leonard James 16Edward Hellriegel 16Jian-Liang Yang 1Wei Xu 17Hui-Qiang Huang 18Xiu-Bin Xiao 19Jun Zhu 20Dao-Bin Zhou 21Xiao-Hong Han1
作者信息
- 1. Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs,Beijing 100021,China
- 2. Department of Oncology,Jiangsu Cancer Hospital & Jiangsu Institute of Cancer,Nanjing,Jiangsu 210009,China
- 3. Department of Oncology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan 450052,China
- 4. Department of Hematology,The First Affiliated Hospital of Zhejiang University College of Medicine,Hangzhou,Zhejiang 310003,China
- 5. Department of Hematology,Peking University Third Hospital,Beijing 100191,China
- 6. Department of Oncology,Jilin University First Affiliated Hospital,Changchun,Jilin 130021,China
- 7. Department of Hematology,Jiangsu Institute of Hematology,The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu 215006,China
- 8. Department of Hematology,Peking University Institute of Hematology,Peking University People's Hospital,Beijing 100044,China
- 9. Department of Hematology,Guangdong General Hospital,Guangzhou,Guangdong 510062,China
- 10. Department of Hematology and Research Laboratory of Hematology,West China Hospital of Sichuan University,Chengdu,Sichuan 610041,China
- 11. Department of Medical Oncology,Harbin Medical University Cancer Hospital,Harbin,Heilongjiang 150001,China
- 12. Department of Medical Oncology,Fudan University Shanghai Cancer Center,Shanghai 200030,China
- 13. Department of Hematology,Chinese PLA General Hospital,Beijing 100038,China
- 14. Department of Hematology,Shanghai Ruijin Hospital,Shanghai 200020,China
- 15. Department of Hematology,The Second Hospital of Lanzhou University,Lanzhou,Gansu 730030,China
- 16. Department of Drug Metabolism and Pharmacokinetics,Teva Branded Pharmaceutical Products R&D Inc.,West Chester,PA 19380,USA
- 17. Department of Hematology,The First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,China
- 18. Department of Medical Oncology,Sun Yat-sen University Cancer Center,Guangzhou,Guangdong 510060,China
- 19. Department of Medical Oncology,307 Hospital of Chinese People's Liberation Army,Beijing 100071,China
- 20. Department of Lymphoma,Peking University Cancer Hospital & Institute,Beijing 100142,China
- 21. Department of Hematology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100730,China
- 折叠
摘要
关键词
Bendamustine/Non-Hodgkin lymphoma/B-cell malignancy/Relapsed disease/Clinical trialKey words
Bendamustine/Non-Hodgkin lymphoma/B-cell malignancy/Relapsed disease/Clinical trial引用本文复制引用
Yuan-Kai Shi,Jian-Qiu Wu,Ming-Zhi Zhang,Jie Jin,Xiao-Yan Ke,Wei Li,De-Pei Wu,Shen-Miao Yang,Xin Du,Yong-Qian Jia,Ai-Chun Liu,Xiao-Nan Hong,Dai-Hong Liu,Zhi-Xiang Shen,Lian-Sheng Zhang,Leonard James,Edward Hellriegel,Jian-Liang Yang,Wei Xu,Hui-Qiang Huang,Xiu-Bin Xiao,Jun Zhu,Dao-Bin Zhou,Xiao-Hong Han..Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma:a multicenter,open-label,single-arm,phase 3 study[J].中华医学杂志（英文版）,2021,134(11):1299-1309,11.基金项目
This study was funded by the Teva Branded Pharmaceuti-cal Products R&D Inc. （）
